#
Progress Update: DUX4 mRNA silencing using CRISPR-Cas13
Oct 25, 2020
Dr. Rashnonejad provides an update on a potential therapeutic.
#
Progress Update: SLC34A2 as a Biomarker for FSHD
Oct 14, 2020
Dr. Bloch provides an update on progress investigating a potential biomarker for FSHD.
#
Progress Update: Clinical Trial Support at University of Washington
Oct 14, 2020
Dr. Wang provides an update on the various studies supported by Friends at the UW.
#
Progress Update: Screening of FDA-approved compounds
Oct 6, 2020
Dr. Lek provides an update on progress establishing a pipeline for testing the therapeutic potential of the drugs to reduce DUX4 toxicity, starting with everolimus.